Stay updated on Nivolumab with Cisplatin-RT in Head and Neck Cancers Clinical Trial
Sign up to get notified when there's something new on the Nivolumab with Cisplatin-RT in Head and Neck Cancers Clinical Trial page.

Latest updates to the Nivolumab with Cisplatin-RT in Head and Neck Cancers Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange Detected- The page footer now displays Revision: v3.3.2, replacing Revision: v3.2.0.SummaryDifference0.1%

- Check20 days agoChange DetectedThe page no longer displays the temporary notice about potential data delays due to government funding lapses and where to check operation status (cc.nih.gov; opm.gov). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check34 days agoChange DetectedThe study page content appears unchanged between the screenshots. No updates to inclusion criteria, primary outcomes, or treatment details are evident.SummaryDifference0.4%

- Check63 days agoChange DetectedCore page updates: added a government funding notice and operating status guidance (high impact); updated version to v3.2.0; removed a specific disease resource (Squamous cell carcinoma of the head and neck) and older version tag v3.1.0.SummaryDifference4%

- Check70 days agoChange DetectedRenamed the condition phrasing to 'Squamous cell carcinoma of the head and neck' and updated the revision version from v3.0.2 to v3.1.0.SummaryDifference0.7%

- Check85 days agoChange DetectedVersion bumped from v3.0.1 to v3.0.2; the previous revision label is removed and the 'Back to Top' link is deleted, with no other substantive changes.SummaryDifference0.2%

Stay in the know with updates to Nivolumab with Cisplatin-RT in Head and Neck Cancers Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab with Cisplatin-RT in Head and Neck Cancers Clinical Trial page.